Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (2)
  • 2023 (8)
  • 2022 (6)
  • 2021 (6)
  • 2020 (4)
  • 2019 (2)

Subject

  • Drug Trafficking (366)
  • Synthetic drugs (178)
  • Guns/Weapons (82)
  • Overdose (57)
  • Prescription Drugs (55)
  • Arrests/Convictions - Major (36)
  • Gangs (34)
  • Take Back Day (33)
  • Diversion Division (31)
  • Major Law Enforcement Operation (27)
  • Outreach/Drug Prevention (25)
  • Fake Pills (23)
  • Public and Media Affairs - also see Congressional Affairs (20)
  • Fentanyl Awareness (15)
  • Money Laundering (15)
  • OCDETF/Task Force (14)
  • Task Forces/Task Force Officers (14)
  • Press Conferences (13)
  • Seizures (Drugs/Property) (13)
  • Congressional Affairs (12)
  • Guilty Plea (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (10)
  • Extraditions (9)
  • Red Ribbon (9)
  • Terrorism (8)
  • One Pill Can Kill (7)
  • International/Foreign Operations (6)
  • Narcoterrorism (5)
  • Dark Web- Internet Trafficking (4)
  • Intergovernmental Affairs (4)
  • Critical Incident (3)
  • HIDTA (2)
  • Scam Calls (2)
  • El Paso Intelligence Center (1)
  • Fentanyl Free America (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Pharmaceuticals/Pharmacists/Physicians (30)

Drug Name

  • Oxycodone (10)
  • Fentanyl (2)
  • Cocaine (1)
  • GHB (1)
  • Ketamine (1)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • New York (21)
  • Headquarters (9)
Clear All Results
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

November 19, 2025
NEW YORK – United States Drug Enforcement Administration (“DEA”) New York Division Special Agent in Charge Frank Tarentino, DEA San Francisco Division Special Agent in Charge Robert Beris, along with our law enforcement partners Homeland Security Investigations (“HSI”) New York , U.S. Department of Health and Human Services – Office...
November 19, 2025
PRESS RELEASE

DEA Safely Disposes of 620,000 Pounds of Unused Medications on 28th National Prescription Drug Take Back Day

May 08, 2025
WASHINGTON – DEA and nearly 4,500 law enforcement agencies joined forces last month to dispose of more than 620,000 pounds of unneeded and expired medications in an effort to prevent drug misuse and abuse. The spring collection event marked DEA’s 28th National Prescription Drug Take Back Day. Since its inception...
May 08, 2025
PRESS RELEASE

Sweeping DEA Operation Targets Pharmacy Burglaries and the Illegal Sale of Addictive Prescription Medications

August 29, 2024
WASHINGTON – The U.S. Drug Enforcement Administration has seen an increase in burglaries at independent pharmacies across the country. Nearly 900 burglaries involving the theft of controlled substances were reported to DEA in 2023. Stolen prescription medications adversely impact these small businesses while also putting patients and the community at...
August 29, 2024
PRESS RELEASE

DEA Announces Settlement with Morris & Dickson Co., LLC

February 07, 2024
WASHINGTON, D.C. – The U.S. Drug Enforcement Administration announced today a settlement with pharmaceutical distributor Morris & Dickson Co., LLC for failing to maintain effective controls against diversion of controlled substances, including failure to report to DEA thousands of unusually large orders of oxycodone and hydrocodone. Morris & Dickson, which...
February 07, 2024
PRESS RELEASE

Fort Salonga Urologist and Wife Charged with Criminal Sale of a Prescription for a Controlled Substance and Falsifying Business Records

December 14, 2023
SUFFOLK COUNTY, N.Y. – Suffolk County District Attorney Raymond A. Tierney and Drug Enforcement Administration Special Agent in Charge Frank A. Tarentino III today announced the indictment of Francis and Jessica Martinis, of Fort Salonga, accused of Criminal Sale of Prescription for a Controlled Substance by a Practitioner and Falsifying...
December 14, 2023
PRESS RELEASE

Queens Pharmacist Sentenced to 60 Months in Prison for Illegally Distributing Oxycodone and Filing False Tax Returns

November 29, 2023
BROOKLYN, N.Y. - Today, Daniel E. Russo was sentenced to 60 months in prison by United States District Judge Dora L. Irizarry for conspiracy to distribute and possess with intent to distribute oxycodone, distribution and possession of oxycodone, and nine counts of filing false personal and corporate tax returns. In...
November 29, 2023
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

October 31, 2023
WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
October 31, 2023
PRESS RELEASE

Nurse Practitioner Arrested, Charged with Selling Oxymorphone

October 05, 2023
BUFFALO, N.Y. - U.S. Attorney Trini E. Ross announced today that Michael Ostolski, 55, of North Tonawanda, NY, was arrested and charged by criminal complaint with conspiracy to distribute oxymorphone. The charge carries a maximum penalty of 20 years in prison and a $1,000,000 fine. Assistant U.S. Attorney Michael J...
October 05, 2023
PRESS RELEASE

Catskill Pharmacy Pays $65,000 to Resolve Controlled Substances Act Allegations

June 22, 2023
ALBANY, NEW YORK – Greene Pharma LLC, dba Greene Medical Arts Pharmacy (Greene Pharma), a pharmacy in Catskill, New York, agreed to pay $65,000 to resolve allegations that it failed to comply with the Controlled Substances Act (CSA). United States Attorney Carla B. Freedman and Special Agent in Charge Frank...
June 22, 2023
PRESS RELEASE

DEA, SAMHSA Extend COVID-19 Telemedicine Flexibilities for Prescribing Controlled Medications for Six Months While Considering Comments from the Public

May 09, 2023
WASHINGTON – Today, ahead of the expiration of the COVID-19 Public Health Emergency (PHE), the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a temporary rule that extends telemedicine flexibilities...
May 09, 2023
Showing 1 - 10 of 30 results

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster